CRT Meeting

CRT Meeting CRT 2025 is an interventional cardiology meeting comprised of concurrent meetings in ten areas of interest. Visit CRTmeeting.org for more information.

CRT is a leading educational forum on new cardiovascular technology and procedures for physicians and health care professionals. Cardiovascular Research Technologies (CRT) is comprised of concurrent meetings in six main areas of interest— Valve & Structural Heart, Coronary, Endovascular, Technology and Innovation, and Nurses & Technologists. CRT provides a forum for exemplary education for interventional cardiologists as well as general cardiologists, cardiothoracic and vascular surgeons, cath lab managers, nurses and technologists, scientists and those with an interest in cardiovascular medicine. Join more than 3,000 interventional and endovascular specialists at CRT 2024 for a comprehensive four-day interventional cardiology conference in Washington, DC from March 9-12. For general inquiries, please email CRTmeeting@gmail.com.

✨Fellows✨ 💙Early Career Leaders💙 🔬Innovators🔬 💃Women in Cardiology💃We have scholarships JUST FOR YOU! Join us for 4 days...
11/26/2025

✨Fellows✨ 💙Early Career Leaders💙 🔬Innovators🔬 💃Women in Cardiology💃
We have scholarships JUST FOR YOU! Join us for 4 days of cardiology content at CRT 2026 ➡️ CRTmeeting.org ⬅️

Apply by December 19, 2025

Patients with atherosclerosis or diabetes who have not experienced myocardial infarction or stroke are at lower risk for...
11/26/2025

Patients with atherosclerosis or diabetes who have not experienced myocardial infarction or stroke are at lower risk for fist cardiovascular events when taking PCSK9 inhibitors plus evolocumab versus placebo, results from the VESALIUS-CV trial show. Read more on CRTonline.

Patients with atherosclerosis or diabetes who have not experienced myocardial infarction (MI) or stroke are at lower risk for fist cardiovascular events when taking PCSK9 inhibitors plus evolocumab ve

A novel transcatheter mitral valve replacement system utilizing atrial fixation achieved 97% technical success with no l...
11/25/2025

A novel transcatheter mitral valve replacement system utilizing atrial fixation achieved 97% technical success with no left ventricular outflow tract obstruction and sustained mitral regurgitation reduction through 6 months, according to early feasibility data from 30 high-risk patients unsuitable for surgery or transcatheter edge-to-edge repair. Read more on CRTonline.

A novel transcatheter mitral valve replacement (TMVR) system utilizing atrial fixation achieved 97% technical success with no left ventricular outflow tract (LVOT) obstruction and sustained mitral reg

Hey nurses and technologists! CRT 2026 has the perfect opportunity for you to showcase your interesting cardiology cases...
11/25/2025

Hey nurses and technologists! CRT 2026 has the perfect opportunity for you to showcase your interesting cardiology cases. Submit your science to our Nurse & Tech Interesting Cases Competition for a chance to WIN ⭐ go to CRTmeeting.org by December 5 to sign up!

11/24/2025

The SELUTION SLR sirolimus-eluting balloon maintained an 81.5% primary patency rate with minimal late catch-up phenomenon through 3 years in patients with symptomatic femoropopliteal disease, marking the first published long-term data for a sirolimus drug-eluting balloon (DEB) in peripheral arterial intervention. Read more on CRTonline. https://ow.ly/C9LU50Xuo1y

11/24/2025

Last call 🗣️ for Abstracts! Submit your Abstracts to CRT 2026 on CRTmeeting.org by 5:00pm ET TONIGHT 🌚🌓🌝

Now is your chance to present your cardiology research to your peers, investigators and experts from around the globe 🌎 don't miss out!

Patients with degenerative mitral regurgitation have similar 1-year survival, safety and quality-of-life gains after mit...
11/23/2025

Patients with degenerative mitral regurgitation have similar 1-year survival, safety and quality-of-life gains after mitral valve transcatheter edge-to-edge repair regardless of baseline extramitral cardiac damage stage, including those with advanced right ventricular dysfunction, according to a new analysis from the CLASP IID randomized trial. Read more on CRTonline. https://ow.ly/97h950XunUa

Nearly half of all revascularization procedures for chronic limb-threatening ischemia (CLTI) are now being performed in ...
11/22/2025

Nearly half of all revascularization procedures for chronic limb-threatening ischemia (CLTI) are now being performed in outpatient settings such as ambulatory surgical centers (ASCs) and outpatient-based laboratories (OBLs), a new study shows. Read more on CRTonline.

Nearly half of all revascularization procedures for chronic limb-threatening ischemia (CLTI) are now being performed in outpatient settings such as ambulatory surgical centers (ASCs) and outpatient-ba

11/21/2025

SURPRISE 🎁 we've extended the Abstract submissions deadline for CRT 2026! Abstracts are now due to CRTmeeting.org by Monday, November 24, 2025 by 5:00pm ET. If you've already procrastinated the deadline, now is your chance to make up for it 😉

11/21/2025

TODAY 🥳🥳🤯 is the LAST DAY to submit your Abstracts to CRT 2026! Bring your cardiology research to Cardiovascular Research Technologies and share your findings 🫀
Submit to CRTmeeting.org by 5:00pm ET!

The integration of renal denervation (RDN) into U.S.-based hypertension care is described in a review as a “guideline-re...
11/20/2025

The integration of renal denervation (RDN) into U.S.-based hypertension care is described in a review as a “guideline-recommended, adjunctive treatment to pharmacotherapy and lifestyle changes for the management of uncontrolled hypertension.” Read more on CRTonline.

The integration of renal denervation (RDN) into U.S.-based hypertension care is described in a review as a “guideline-recommended, adjunctive treatment to pharmacotherapy and lifestyle changes for the

11/20/2025

ONE DAY LEFT!!! 1️⃣ day to submit your Abstracts to CRTmeeting.org for a chance to present your cardiology research at our annual meeting. Present alongside your peers and bring new ideas to the field 💙

Address

Washington D.C., DC

Telephone

+12028777000

Website

Alerts

Be the first to know and let us send you an email when CRT Meeting posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CRT Meeting:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

CRT is a leading educational forum on new cardiovascular technology and procedures for physicians and health care professionals. Cardiovascular Research Technologies (CRT) is comprised of concurrent meetings in six main areas of interest— Valve & Structural Heart, Coronary, Endovascular, Technology and Innovation, and Nurses & Technologists. CRT provides a forum for exemplary education for interventional cardiologists as well as general cardiologists, cardiothoracic and vascular surgeons, cath lab managers, nurses and technologists, scientists and those with an interest in cardiovascular medicine. Join more than 2,000 interventional and endovascular specialists at CRT 2020 for a comprehensive four-day interventional cardiology conference in National Harbor, MD, from February 22-25, 2020. For general inquiries, please email CRTmeeting@gmail.com.